BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3195336)

  • 1. Somatonorm post-marketing surveillance study (UK and Ireland, 1986-1987): a preliminary report.
    Wild RN
    Acta Paediatr Scand Suppl; 1988; 343():89-94. PubMed ID: 3195336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The biosynthetic human growth hormone (Somatonorm) in the treatment of children with growth hormone deficiency].
    Banićević M; Joksimović I; Zdravković D
    Srp Arh Celok Lek; 1987 Jan; 115(1):25-39. PubMed ID: 3672230
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of the treatment of growth hormone deficiency with methionine-somatotropin or recombinant somatotropin].
    Dorantes-Alvarez LM
    Bol Med Hosp Infant Mex; 1990 Jun; 47(6):369-71. PubMed ID: 2222818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience of somatrem: UK preliminary report.
    Milner RD
    Acta Paediatr Scand Suppl; 1986; 325():25-8. PubMed ID: 3296636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose effects of growth hormone during puberty.
    Saenger P
    Horm Res; 2003; 60(Suppl 1):52-7. PubMed ID: 12955018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of growth hormone deficiency through puberty.
    Stanhope R; Uruena M; Hindmarsh P; Leiper AD; Brook CG
    Acta Paediatr Scand Suppl; 1991; 372():47-52; discussion 53. PubMed ID: 1927519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the clinical use and experience of Somatonorm (somatrem).
    Flodh H
    Acta Paediatr Scand Suppl; 1987; 337():130-3. PubMed ID: 3481179
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial with somatonorm in idiopathic growth hormone deficiency in children.
    Shi YF; Liu R; Bao XL; Deng JY; Gunnarsson R
    Chin Med J (Engl); 1990 Jun; 103(6):470-7. PubMed ID: 2119959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human growth hormone therapy: longterm responses in 30 children with growth hormone deficiency.
    Kannan V; Usharani K
    Indian J Pediatr; 1991; 58 Suppl 1():65-9. PubMed ID: 1824378
    [No Abstract]   [Full Text] [Related]  

  • 10. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone dose-dependent pubertal growth: a randomized trial in short children with low growth hormone secretion.
    Albertsson-Wikland K; Kriström B; Lundberg E; Aronson AS; Gustafsson J; Hagenäs L; Ivarsson SA; Jonsson B; Ritzén M; Tuvemo T; Westgren U; Westphal O; Aman J
    Horm Res Paediatr; 2014; 82(3):158-70. PubMed ID: 25170833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unfavorable effects of growth hormone therapy on the final height of boys with short stature not caused by growth hormone deficiency.
    Kawai M; Momoi T; Yorifuji T; Yamanaka C; Sasaki H; Furusho K
    J Pediatr; 1997 Feb; 130(2):205-9. PubMed ID: 9042121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone secretion and response to growth hormone therapy after treatment for brain tumour.
    Lannering B; Marky I; Mellander L; Albertsson-Wikland K
    Acta Paediatr Scand Suppl; 1988; 343():146-51. PubMed ID: 3143223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences of Somatonorm in Sweden.
    Westphal O
    Acta Paediatr Scand Suppl; 1986; 325():41-4. PubMed ID: 3296639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating growth hormone treatment.
    Wardhaugh B
    Nurs Stand; 1992 Aug 19-25; 6(48):33-6. PubMed ID: 1515332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa.
    van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koèelega AC
    J Clin Endocrinol Metab; 2016 May; 101(5):2005-12. PubMed ID: 26964733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature.
    Wit JM; Kamp GA; Rikken B
    Pediatr Res; 1996 Feb; 39(2):295-302. PubMed ID: 8825803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of first-year growth response to a fixed-dose growth hormone treatment in children born small for gestational age: results of an open-label, multicenter trial in the United States.
    Rapaport R; Saenger P; Wajnrajch MP;
    J Pediatr Endocrinol Metab; 2008 May; 21(5):411-22. PubMed ID: 18655522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.